Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the ...

The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the ...

COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...

The U.S. Food and Drug Administration has revoked the Emergency Use Authorization for bamlanivimab administered alone, bamlanivimab and ...

Anumigilimab is under clinical development by CSL and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Press Release - Vaccination remains an important public health countermeasure against COVID-19. As per the WHO Director ...

An MOH spokesman said that in general, the Covid-19 situation here has been stable. Read more at straitstimes.com.

The US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based ...